Project Dulce for Filipino-Americans With Type 2 Diabetes

Launched by SCRIPPS WHITTIER DIABETES INSTITUTE · May 13, 2022

Keywords

ClinConnect Summary

This clinical trial, called Project Dulce, is designed to help Filipino-Americans with type 2 diabetes manage their condition better. The study will adapt an existing diabetes education program to fit the cultural needs of Filipino-Americans and include a text messaging support system called Dulce Digital. This is important because it aims to address unique challenges faced by this community, such as language barriers and access to technology. Researchers will evaluate how effective this adapted program is in improving participants' understanding of diabetes, their health behaviors, and their blood sugar levels over a period of three to six months.

To participate, individuals must be self-identified Filipino-Americans, have been diagnosed with type 2 diabetes, and meet certain health criteria, including having a specific blood test result. Participants should be comfortable speaking and reading in both English and Tagalog. They can expect to receive support and information tailored to their needs, helping them improve their diabetes management. The study is currently recruiting participants, and it aims to provide valuable insights into how best to support Filipino-Americans living with diabetes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Self-identified Filipino
• • Diagnosed with T2DM
• • Registered at Scripps Health or San Ysidro Health (or willing to register)
• • HbA1c ≥7.5% and/or systolic blood pressure ≥ 140, and/or LDL-C ≥ 100 mg/dL within 90 days
• • Able to speak, read, write, and comprehend in English and Tagalog
• • Have access to a cell phone that can receive/send text messages throughout the study
• Exclusion Criteria:
• • Severe illness precluding frequent visits to clinic
• • Liver function tests (ALT and AST) \> 3 times the upper limit of normal
• • Body mass index ≤ 23 kg/cm
• • History of malignancy, except subjects who have been disease-free for \>years, or whose only malignancy has been basal or squamous cell skin carcinoma
• • Creatinine \>3.5
• • History of drug or alcohol abuse within 12 months prior to enrollment
• • Not a permanent resident in the area
• • Current enrollee in Project Dulce
• • Blood donation of one pint or more within the past 30 days, or plasma donation within 7 days prior to screening
• • Anemia
• • Type 1 or gestational diabetes
• • Pregnant
• • Are currently participating in another diabetes-related study